John C. Jacobs - 23 Jan 2026 Form 4 Insider Report for NOVAVAX INC (NVAX)

Role
President and CEO, Director
Signature
/s/ Mark J. Casey, Attorney-in-Fact
Issuer symbol
NVAX
Transactions as of
23 Jan 2026
Net transactions value
-$358,840
Form type
4
Filing time
26 Jan 2026, 19:57:59 UTC
Previous filing
05 Mar 2025
Next filing
03 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Jacobs John C President and CEO, Director 21 FIRSTFIELD ROAD, GAITHERSBURG /s/ Mark J. Casey, Attorney-in-Fact 26 Jan 2026 0001820836

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVAX Common Stock Options Exercise $0 +83,197 +61% $0.000000 219,929 23 Jan 2026 Direct
transaction NVAX Common Stock Tax liability $358,840 -39,132 -18% $9.17 180,797 23 Jan 2026 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NVAX Restricted Stock Units Options Exercise $0 -83,197 -100% $0.000000 0 23 Jan 2026 Common Stock 83,197 $0.000000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of the grant date, in each case subject to continued employment through such vesting date.